European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe
BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) today announced that the European Commission has approved the use of Symtuza®(darunavir/cobicistat/emtricitabine/tenofovir......